{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Irvine",
      "state": "CA",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "71078",
      "recalling_firm": "South Coast Specialty Compounding, Inc.",
      "address_1": "9257 Research Dr",
      "address_2": "N/A",
      "postal_code": "92618-4286",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide.",
      "recall_number": "D-1337-2015",
      "product_description": "Bi-Est 80:20 Progesterone (estriol,estradiol, progesterone) capsules, Rx only,  Manufactured by Park Compounding, Irvine, CA",
      "product_quantity": "ALL LOTS",
      "reason_for_recall": "Penicillin Cross Contamination: Multiple finished products potentially contaminated with penicillin.",
      "recall_initiation_date": "20150423",
      "center_classification_date": "20150902",
      "termination_date": "20160531",
      "report_date": "20150909",
      "code_info": "All Lots, Exp 09/15"
    }
  ]
}